Cargando…

Comparison of Survival Outcomes of Single- and Five-Fraction Schedules of Stereotactic Body Radiation Therapy for Early-Stage Central or Peripheral NSCLC

SIMPLE SUMMARY: Patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) often receive different treatment regimens based on the location of the tumor to minimize the risk of severe side effects. The aim of our study was to examine survival...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Karen, Prasad, Sharan, Ma, Sung Jun, Iovoli, Austin J., Farrugia, Mark K., Malik, Nadia K., Singh, Anurag K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046844/ https://www.ncbi.nlm.nih.gov/pubmed/36980533 http://dx.doi.org/10.3390/cancers15061648

Ejemplares similares

Association of neutrophil–lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy
por: Huang, Karen, et al.
Publicado: (2023)

Quality of Life After Stereotactic Body Radiation Therapy or Surgery for Early-Stage NSCLC: A Systematic Review
por: Iovoli, Austin J., et al.
Publicado: (2022)

Right Atrial Dose Is Associated with Worse Outcome in Patients Undergoing Definitive Stereotactic Body Radiation Therapy for Central Lung Tumors
por: Farrugia, Mark, et al.
Publicado: (2022)

Comparison of single– and five–fraction schedules of stereotactic body radiation therapy for central lung tumours: a single institution experience
por: Ma, Sung Jun, et al.
Publicado: (2017)

Evaluation of Preoperative Chemotherapy or Radiation and Overall Survival in Patients With Nonmetastatic, Resectable Retroperitoneal Sarcoma
por: Ma, Sung Jun, et al.
Publicado: (2020)

Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation
por: Repka, Michael C., et al.
Publicado: (2017)

Prophylactic High-Dose Gabapentin Reduces Opiate Use during Radiation Therapy for Head and Neck Squamous Cell Carcinoma
por: Qiu, Michelle L., et al.
Publicado: (2023)

The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
por: Shibamoto, Yuta, et al.
Publicado: (2020)

Accupuncture-like transcutaneous electrical nerve stimulation therapy success using a commercially available unit 8 years post-radiation for xerostomia: a case report
por: Iovoli, Austin J., et al.
Publicado: (2017)

Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic review
por: Zehentmayr, Franz, et al.
Publicado: (2020)

Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer
por: Iovoli, Austin J., et al.
Publicado: (2023)

Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016)

Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done
por: Bartl, Austin J., et al.
Publicado: (2022)

Association of Gabapentin Use With Pain Control and Feeding Tube Placement Among Patients With Head and Neck Cancer Receiving Chemoradiotherapy
por: Ma, Sung Jun, et al.
Publicado: (2022)

Trends in Postoperative Intensity-Modulated Radiation Therapy Use and Its Association With Survival Among Patients With Incompletely Resected Non–Small Cell Lung Cancer
por: Yu, Brian, et al.
Publicado: (2022)

Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases
por: Lischalk, Jonathan W., et al.
Publicado: (2015)

Fractionated Stereotactic Radiation for Central Nervous System Lymphoma: Retrospective Analysis of Initial Cases
por: Schep, Daniel G., et al.
Publicado: (2023)

Fractionated stereotactic radiation therapy for intact brain metastases
por: Marcrom, Samuel R., et al.
Publicado: (2017)

Dosimetric comparison of CT-guided iodine-125 seed stereotactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC
por: Li, Ranran, et al.
Publicado: (2017)

Five-Fraction Stereotactic Radiotherapy for Brain Metastases—A Retrospective Analysis
por: Layer, Julian P., et al.
Publicado: (2023)

Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation
por: Hassanzadeh, Comron, et al.
Publicado: (2020)

Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)
por: Kraus, K. M., et al.
Publicado: (2021)

Racial/Ethnic Differences and Trends in Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer
por: Ma, Sung Jun, et al.
Publicado: (2022)

The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules
por: Arnold, Kimberly M, et al.
Publicado: (2018)

Reirradiation of recurrent salivary gland malignancies with fractionated stereotactic body radiation therapy
por: Karam, Sana D., et al.
Publicado: (2012)

Evaluation of radiation treatment volumes for unknown primaries of the head and neck in the era of FDG PET
por: Platek, Alexis, et al.
Publicado: (2020)

A single institutional experience with central lung stereotactic body radiation therapy demonstrating encouraging results with increased inter-fraction time
por: Kowalchuk, Roman O., et al.
Publicado: (2021)

Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14)
por: Martel-Lafay, Isabelle, et al.
Publicado: (2021)

Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy
por: Kelley, K. D., et al.
Publicado: (2015)

A Principal Component of Quality-of-Life Measures Is Associated with Survival: Validation in a Prospective Cohort of Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy
por: Farrugia, Mark K., et al.
Publicado: (2021)

Spatially fractionated stereotactic body radiation therapy (Lattice) for large tumors
por: Duriseti, Sai, et al.
Publicado: (2021)

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer
por: Zarębska, Izabela, et al.
Publicado: (2023)

Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression
por: Thirion, Pierre G., et al.
Publicado: (2020)

Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications
por: Abel, Stephen, et al.
Publicado: (2019)

Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid
por: Wegner, Rodney E, et al.
Publicado: (2019)

Definitive Radiation Therapy for Early Glottic Cancer: Experience of Two Fractionation Schedules
por: Kim, Tae Gyu, et al.
Publicado: (2012)

Single-fraction Stereotactic Body Radiation Therapy versus Conventionally Fractionated Radiation Therapy for the Treatment of Prostate Cancer Bone Metastases
por: Gao, Robert W., et al.
Publicado: (2019)

Hypofractionated Stereotactic Radiotherapy in Five Daily Fractions for Post-Operative Surgical Cavities in Brain Metastases Patients with and without Prior Whole Brain Radiation
por: Al-Omair, Ameen, et al.
Publicado: (2013)

Stereotactic body radiation therapy for centrally-located lung tumors
por: SHEN, GE, et al.
Publicado: (2014)

Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases
por: Johannwerner, Leonie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b64uc4u7pmca32r9c38dumnhu2